Virginia Retirement Systems Et Al Royalty Pharma PLC Transaction History

Virginia Retirement Systems Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 11, 2023	SELL	$32.77 - $39.4 $7.05 Million - $8.48 Million	-215,151 Reduced 49.26%	221,649 $7.99 Million
Q4 2022 May 17, 2023	BUY	$39.17 - $44.04 $3.77 Million - $4.24 Million	96,200 Added 28.24%	436,800 $17.3 Billion
Q3 2022 May 16, 2023	BUY	$39.88 - $44.65 $8.65 Million - $9.68 Million	216,800 Added 175.12%	340,600 $13.7 Billion
Q1 2022 Apr 21, 2022	BUY	$37.46 - $42.44 $206,030 - $233,420	5,500 Added 4.65%	123,800 $4.82 Million
Q3 2021 Oct 21, 2021	BUY	$36.14 - $42.24 $3.61 Million - $4.22 Million	100,000 Added 546.45%	118,300 $4.28 Million
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $729,255 - $853,329	18,300 New	18,300 $750,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.